REXAHN PHARMACEUTICALS INC (RNN) Stock Price, Quote, News and Overview
NYSEARCA:RNN - NYSE Arca -
RNN Quote, Performance and Key Statistics
NYSEARCA:RNN (6/7/2019, 8:25:25 PM)
5.24
+0.01 (+0.19%)
The current stock price of RNN is 5.24 null. In the past month the price decreased by -10.27%. In the past year, price decreased by -76.52%.
About RNN
Company Profile
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.
Company Info
REXAHN PHARMACEUTICALS INC
15245 SHADY GROVE ROAD SUITE 455
ROCKVILLE MD 20850
CEO: Douglas J. Swirsky
Phone: 240-268-5300
REXAHN PHARMACEUTICALS INC / RNN FAQ
What is the stock price of REXAHN PHARMACEUTICALS INC today?
The current stock price of RNN is 5.24 null. The price increased by 0.19% in the last trading session.
What is the ticker symbol for REXAHN PHARMACEUTICALS INC stock?
The exchange symbol of REXAHN PHARMACEUTICALS INC is RNN and it is listed on the NYSE Arca exchange.
On which exchange is RNN stock listed?
RNN stock is listed on the NYSE Arca exchange.
What is REXAHN PHARMACEUTICALS INC worth?
REXAHN PHARMACEUTICALS INC (RNN) has a market capitalization of 21.06M null. This makes RNN a Nano Cap stock.
What are the support and resistance levels for REXAHN PHARMACEUTICALS INC (RNN) stock?
REXAHN PHARMACEUTICALS INC (RNN) has a support level at 4.82 and a resistance level at 5.38. Check the full technical report for a detailed analysis of RNN support and resistance levels.
Should I buy REXAHN PHARMACEUTICALS INC (RNN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RNN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RNN, evaluating the profitability, health, valuation and growth aspects
- REXAHN PHARMACEUTICALS INC (RNN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REXAHN PHARMACEUTICALS INC (RNN) Sales and EPS estimates to see what analysts future expectations are.
- REXAHN PHARMACEUTICALS INC (RNN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REXAHN PHARMACEUTICALS INC (RNN) Insider and Institutional Ownership to learn about the owners and their transactions.
- REXAHN PHARMACEUTICALS INC (RNN) Stock Chart to make your own analysis
- REXAHN PHARMACEUTICALS INC (RNN) Latest news and press-releases to stay up to date.
Does REXAHN PHARMACEUTICALS INC (RNN) stock pay dividends?
RNN does not pay a dividend.
What is the Price/Earnings (PE) ratio of REXAHN PHARMACEUTICALS INC (RNN)?
REXAHN PHARMACEUTICALS INC (RNN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.53).
RNN Technical Analysis
RNN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RNN. The financial health of RNN is average, but there are quite some concerns on its profitability.
RNN Financial Highlights
Over the last trailing twelve months RNN reported a non-GAAP Earnings per Share(EPS) of -3.53. The EPS decreased by -498.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -75.35% | ||
| ROE | -91.82% | ||
| Debt/Equity | 0.01 |
RNN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to RNN. The Buy consensus is the average rating of analysts ratings from 3 analysts.